Aegea for Patients

Women experienced an improved quality of life after treatment with the AEGEA Vapor System for endometrial ablation.

What to Expect, Risks & Considerations

Endometrial ablation with the AEGEA Vapor System is a surgical procedure.

Prior to coming into the treatment room, you may be asked to take specific medications at the direction of your physician. These medications are intended to help you relax during the procedure.

The procedure may be performed in the doctor’s office. General anesthesia is not required. Your uterus will be accessed through your vagina. There are no incisions. The procedure takes about 4 minutes to complete including 2 minutes of vapor treatment.

After the procedure, you may experience some mild to moderate low abdominal cramping and pain. You may be given some medication for this. You will then be released to go home.

Most patients experience some uterine cramping for a few days, which usually is treated with over-the-counter (non-prescription) pain medication that your doctor will recommend. Patients also reported vaginal discharge following the procedure.

IMPORTANT SAFETY INFORMATION

As with all surgical procedures, there are risks and considerations associated with the AEGEA Vapor System. Please refer to the Patient Labeling for a detailed discussion of the device’s intended use, relevant warnings, precautions, side effects and contraindications.

The AEGEA Vapor System has been shown in clinical studies to effectively reduce heavy menstrual bleeding. One year after the treatment in the Pivotal Study, the following results were seen:

  • 6X reduction in heavy menstrual bleeding per Pivotal Study criteriaa
  • 90% had bleeding reduced by ≥50%
  • 85% had bleeding that was reduced to a normal level or less per scientific literatureb

Improved Quality of Life and Patient Satisfaction

Patients reported improved quality of life and high satisfaction with the AEGEA procedure. One year after the treatment in the Pivotal Study, patients reported the following:

  • 99% of patients experienced and improvement in quality of life
  • 93% of patients said they would recommend the procedure to a friend
  • 91% of patients were either satisfied or very satisfied

Return to Work

Patients reported a quick return to work following the AEGEA procedure. Patients in the Pivotal Study reported the following:

  • 89% of patients returned to work within 3 days or less
  • 79% of patients returned to work within 2 days or less

Menstrual Cramping

Patients with menstrual cramping before the procedure reported a decrease in menstrual cramping. One year after the treatment in the Pivotal Study, patients reported the following:

  • 72% of patients with menstrual cramping before undergoing the procedure said their cramping decreased after the AEGEA procedure

Sex Life

Patients whose periods affected their sex life, reported an improvement in their sex life. One year after the treatment in the Pivotal Study, patients reported the following:

  • 85% of patients whose periods affected their sex life had an improvement in their sex life after treatment
A natural choice. A new freedom.